Navigation Links
Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm
Date:4/22/2009

DALLAS, April 22 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced today that MuGard(TM), its proprietary polymer-based oral mucositis product has been launched in Germany, Italy, UK, Greece and the Nordic countries by its European commercial partner, SpePharm, a pan-European specialty pharmaceutical company dedicated to the provision of high medical value medicines in supportive and critical care.

Under a license from Access Pharmaceuticals Inc, SpePharm is responsible for manufacturing, regulatory approval and commercialization in the 27 countries of Europe. In October 2008, MuGard was granted CE Mark certification by the Dutch Notified Body (KEMA). SpePharm plans to launch MuGard in the rest of Europe over the coming 12 to 18 months. Access will receive significant royalties on net sales.

"SpePharm and Access are pleased with the commercial launch of MuGard in Europe, and while it is still in the early days, initial feedback has been positive," said Phillip Wise, Vice President of Business Development at Access. "SpePharm is also working hard to secure reimbursement from the individual governmental regulators, which we believe will greatly enhance initial product adoption and ongoing marketing efforts to reach and penetrate the target population of patients requiring this important treatment option. We look forward to further commercial launches from our other MuGard commercialization partners," he continued.

MuGard is a ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and/or radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevent
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting
2. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
3. New organic material may speed Internet access
4. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
5. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
6. Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal
7. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference
8. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
9. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
10. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
11. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Contec’s Sporicidin disinfectant solut...grade disinfectants against H1N1 and Influenza A.,...) November 24, 2009 -- Contec Inc, the leading man...that their Sporicidin disinfectants have been de... A viruses, including Pandemic 2009 H1N1 influenza...
(Date:11/23/2009)...ov.23/PRNewswire/-InimexPharmaceuticals,Inc.announ...sPresidentandCEO. ,, Abramsbringsmorethan25year...eisaco-inventorofthenuclearmedicineimagingagent,Ca...lcwherehewasManager,BiomedicalResearchWorldwide.In...CandwasPresidentandCEOfrom1996to2006.AnorMEDdiscov...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...eguard Mezzanine Debt Facility; Support Profitable...nt , Inc. (Nasdaq: CLRT ), a premier anatomic p...or pathologists, oncologists and the pharmaceutica...the second tranche of a private placement of conve...ers , a multi-stage venture capital firm based in...
...a-FirstCall/ -- China Dasheng,Biotechnology Compan... Board:,CDBT), a leading producer and distributor ...livestock feeds in the PRC, announced unaudited fi...ar 2009, which ended March 31, 2009. , , Highli... -- Total revenue grew approximately 43% to $5....
...ia-FirstCall/ -- Rodobo International,Inc. (OTC Bu...t dairy,companies in China, reported financial res...nded March 31, 2009. , Second quarter financia... quarter ended March 31, 2009 was $6.3 million, an...e was primarily driven by,volume growth, with aver...
Other Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 2China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 3China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 4China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 5China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 7China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 8Rodobo International, Inc. Reports Q2 and First Half of 2009 2Rodobo International, Inc. Reports Q2 and First Half of 2009 3Rodobo International, Inc. Reports Q2 and First Half of 2009 4Rodobo International, Inc. Reports Q2 and First Half of 2009 5Rodobo International, Inc. Reports Q2 and First Half of 2009 6Rodobo International, Inc. Reports Q2 and First Half of 2009 7Rodobo International, Inc. Reports Q2 and First Half of 2009 8
(Date:11/23/2009)...g of recent discoveries about the multiple health ... multi-purpose nutrient, increased awareness of th...spurred research and even led to an appreciation o...ng from the health of your immune system to preven...fluenza, vitamin D is now seen as one of the most ...
(Date:11/23/2009)...sify the gender of six-week-old turkey poults coul...hortly after birth, according to Dr. Gerald Steine...many and his team. Their use of infrared spectrosc...hat it is a fast and accurate method with the pote...ify and select female eggs for breeding. The pilot...
(Date:11/23/2009)...le in German . , A bit of imagination on th... thing. It could help to add data from areas where...must do so constructively. In order to infer missi...han just imagination, physicists at the Max Planck...ry of spatial perception called information field ...
Breaking Biology News(10 mins):Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Rescuing male turkey chicks 2Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Delcath Systems Inc Prices 2430 6 Million Stock Offering 6237 1Delcath Systems Inc Prices 2430 6 Million Stock Offering 6237 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 33SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 43SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 53SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 63SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 73SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 83SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 93SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 103SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 113SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 123SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 133SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 143SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 153SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 163SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 173SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 183SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 193SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 203SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 21Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 1Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 2Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 3
...ate University have made a major discovery on the ...anisms of one of life,s most elemental functions: ... for how a normal cell forms a tumor and how a vir...13 edition of the scientific journal Molecular Cel...ds exquisite nanotechnology in living systems and ...
...d be saved if $5.1 billion in new resources for pr...ed each year, according to researchers from the Jo...other institutions. Approximately 90 percent of al...rld. In those countries, the average cost per chil...e recent publication of the potential impact of pr...
...rthern and southern hemispheres are linked by a ph...ither side of the planet. A research team from the... University has shown for the first time that ocea...he past, adapted to sudden changes in the north. T... more accurate forecasts to be made on how the oce...
Other Biology News:High fidelity keeps human DNA assembly line humming 2$5.1 billion would save 6 million children 2$5.1 billion would save 6 million children 3Climatologists discover deep-sea secret 2
Rabbit Anti-Smac / DIABLO, C Terminus Antibody, Unconjugated from BACHEM
Mouse Anti-Integrin alpha M Monoclonal Antibody, Unconjugated, Clone ICRF 44 from Novus Biologicals
Finnpipette Focus Single Channel Long Tip Cone 30-300l from Thermo Scientific
...ion system for small volumes of precious solution ...neral liquid-handling research applications. Del...s. Switch between four or eight solutions in milli...nation with BackStop back-flow prevention. Special...
Biology Products: